Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
JCO Oncology Practice|July 29, 2025
Teaching Communication Skills and Developing Comfort With Difficult Conversations: A Combined Palliative Care-Oncology Simulation Session for Hematology/Oncology FellowsMegan M Dupuis, Katherine J Walsh, Rajiv AgarwalMedical Science Educator|January 20, 2026
Fostering Lifelong Learning: Integrating a Portfolio Coaching Program into an Undergraduate Medical Education (UME) Competency-Based CurriculumCalvin L Gruss, Katherine J Walsh, William B Cutrer, et al.Clinical Lymphoma & Myeloma|February 28, 2007
Discordant expression of CD20 by flow cytometry and immunohistochemistry in a patient responding to rituximab: an unusual mechanismKatherine J Walsh, Samer Z Al-Quran, Ying Li, et al.Journal of General Internal Medicine|June 17, 2022
Innovation and Missed Opportunities in Internal Medicine Undergraduate Education During COVID-19: Results from a National SurveyIrene Alexandraki, Katherine J Walsh, Temple Ratcliffe, et al.American Journal of Hematology|August 11, 2020
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromeCaner Saygin, Karilyn Larkin, James S Blachly, et al.Haematologica|March 24, 2018
A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485Alice S Mims, Anjali Mishra, Shelley Orwick, et al.Cancer|December 7, 2017
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemiaGail J Roboz, Hagop M Kantarjian, Karen W L Yee, et al.The Lancet. Oncology|August 29, 2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trialHagop M Kantarjian, Gail J Roboz, Patricia L Kropf, et al.Pageof 1